{
  "state": "illinois",
  "path": "title-chapter-410-public-health/chapter-410-ilcs-720-drug-take-back-act",
  "sections": [
    {
      "id": "section-1",
      "number": "1.",
      "heading": "Short title. This Act may be cited as the Drug Take-Back Act.",
      "text": "Short title. This Act may be cited as the Drug Take-Back Act.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-5",
      "number": "5.",
      "heading": "Findings. The General Assembly finds that:",
      "text": "Findings. The General Assembly finds that:",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-10",
      "number": "10.",
      "heading": "Definitions. In this Act:",
      "text": "Definitions. In this Act:",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-15",
      "number": "15.",
      "heading": "Participation in a drug take-back program",
      "text": "Each covered manufacturer must, beginning January 1, 2024 or 6 months after becoming a covered manufacturer, whichever is later, individually or collectively implement an approved drug take-back program that complies with the requirements of this Act. A cov",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-20",
      "number": "20.",
      "heading": "Identification of covered manufacturers.",
      "text": "Identification of covered manufacturers.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-25",
      "number": "25.",
      "heading": "Drug take-back program requirements.",
      "text": "Drug take-back program requirements.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-30",
      "number": "30.",
      "heading": "Manufacturer program operator requirements. A manufacturer program operator shall:",
      "text": "Manufacturer program operator requirements. A manufacturer program operator shall:",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-35",
      "number": "35.",
      "heading": "Drug take-back program approval.",
      "text": "Drug take-back program approval.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-40",
      "number": "40.",
      "heading": "Changes or modifications to the approved manufacturer drug take-back program",
      "text": "A manufacturer program operator shall maintain records for 5 years of any changes to an approved drug take-back program. These include, but are not limited to, changes in:",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-45",
      "number": "45.",
      "heading": "Drug take-back program promotion",
      "text": "Each drug take-back program must include a system of promotion, education, and public outreach about the proper collection and management of covered drugs. If there is more than one drug take-back program operated by more than one manufacturer program operator, the",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-50",
      "number": "50.",
      "heading": "Annual program report.",
      "text": "Annual program report.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-55",
      "number": "55.",
      "heading": "Manufacturer drug take-back program funding.",
      "text": "Manufacturer drug take-back program funding.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-60",
      "number": "60.",
      "heading": "Registration fee.",
      "text": "Registration fee.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-65",
      "number": "65.",
      "heading": "Rules; enforcement; penalties.",
      "text": "Rules; enforcement; penalties.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-70",
      "number": "70.",
      "heading": "Antitrust immunity.  The activities authorized by this Act require collaboration among covered manufacturers and among authorized collectors",
      "text": "These activities will enable safe and secure collection and disposal of covered drugs in Illinois and are therefore in the best interest of the public. The be",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-75",
      "number": "75.",
      "heading": "Public disclosure. Proprietary information submitted to the Agency under this Act is exempted from disclosure as provided under paragraphs (g) and (mm) of subsection (1) of Section 7 of the Freedom of Information Act",
      "text": "Public disclosure. Proprietary information submitted to the Agency under this Act is exempted from disclosure as provided under paragraphs (g) and (mm) of subsection (1) of Section 7 of the Freedom of Information Act.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-90",
      "number": "90.",
      "heading": "Home rule.",
      "text": "Home rule.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-95",
      "number": "95.",
      "heading": "(Amendatory provisions; text omitted).",
      "text": "(Amendatory provisions; text omitted).",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-100",
      "number": "100.",
      "heading": "(Amendatory provisions; text omitted).",
      "text": "(Amendatory provisions; text omitted).",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-999",
      "number": "999.",
      "heading": "Effective date. This Act takes effect upon becoming law.",
      "text": "Effective date. This Act takes effect upon becoming law.",
      "history": "",
      "source_url": ""
    }
  ]
}